Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001608936-25-000010

PRESIDENT AND CEO sold 37,461 shares at $12.32 ($461,520)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chacko Jacob PRESIDENT AND CEO 2025-10-06 Sale 10b5-1 −37,461 $12.32 $461,520 531,419 D
Open-market sales · 37,461 sh · avg $12.32 · $461,520
Loading xslF345X05/form4-10082025_091029.xml…